Overview

Mobilization of Endothelial Progenitor Cells and Aspirin

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Aspirin at doses used during acute myocardial infarction may inhibit the mobilization of endothelial progenitor cells (EPCs).
Phase:
Phase 3
Details
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Treatments:
Aspirin
Ethanol